Sophomer

Prague, Czech Republic

Sophomer provides artificial polymers made to replace the bovine serum albumin that is used in immunological tests.

$369K raised

Mar 2023

Seed

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Sophomer raised?

Sophomer has raised $369K in total funding. The most recent round was Seed. The last funding was announced in March 2023.

Who are Sophomer's investors?

Sophomer's investors include i&i Prague, i&i Biotech Fund.

Where is Sophomer headquartered?

Sophomer is headquartered in Prague, Czech Republic.

What does Sophomer do?

Sophomer provides artificial polymers made to replace the bovine serum albumin that is used in immunological tests.

What stage is Sophomer at?

Sophomer is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 29, 2023.

MLA

"Sophomer — Funding & Investors." VCBacked, March 29, 2023, https://www.vcbacked.co/company/sophomer. Accessed July 2, 2026.

APA

VCBacked. (2023). Sophomer — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/sophomer

Wikipedia (cite web)

{{cite web |title=Sophomer — Funding & Investors |url=https://www.vcbacked.co/company/sophomer |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 29, 2023.